Human Papillomavirus (HPV)
Human papillomavirus (HPV) is a common virus with over 100 different types, some of which are linked to various cancers, most notably cervical cancer. HPVs infect epithelial cells, often in the genital or oral areas, and can lead to benign lesions like warts or malignant transformations in host cells.
In the context of cervical cancer, high-risk HPV types (especially HPV-16 and HPV-18) integrate their DNA into the host cell genome, potentially leading to the overexpression of viral oncogenes. These oncogenes can interfere with normal cell cycle regulation and promote resistance to apoptosis, facilitating uncontrolled cell division and tumor development.
Cervical Cancer
Cervical cancer arises from the cervix and is closely linked with HPV infection, particularly persistent infections with high-risk HPV types. The transformation from a benign infection to a malignant tumor involves multiple steps, including the integration of HPV DNA into the host genome, the overexpression of viral proteins (E6 and E7), and the disruption of tumor suppressor functions like those performed by Rb protein and p53.
This interference with tumor suppressor mechanisms leads to the loss of control over the cell cycle and evasion of apoptosis, two cellular hallmarks of cancer development.
Epstein-Barr Virus
The Epstein-Barr virus (EBV) is a member of the herpesvirus family and is best known for causing infectious mononucleosis ('mono'). However, EBV infection is also associated with various lymphoid and epithelial cancers, such as Burkitt lymphoma and nasopharyngeal carcinoma.
EBV contributes to oncogenesis by expressing viral proteins that interfere with cell cycle regulation and apoptosis, like the protein that binds to Rb, which displaces the E2F transcription factor and leads to the deregulation of the cell cycle progression.
Apoptosis
Apoptosis is the process of programmed cell death that removes damaged or unwanted cells in an organized manner. This process is critical for maintaining tissue homeostasis and preventing the development of cancer.
Viruses like HPV and EBV can alter apoptosis pathways to promote cell survival, thereby allowing the infected cells harboring viral oncogenes to evade the immune system and accumulate additional genetic damage, which can contribute to the transformation into cancer cells.
Cell Cycle
The cell cycle is an ordered set of events leading to cell division and the replication of its DNA to produce two daughter cells. The cycle is divided into four main phases: G1, S (DNA synthesis), G2, and M (mitosis).
Regulatory checkpoints at different phases ensure DNA integrity and proper cell growth. Viral oncogenes can disrupt the control over these checkpoints, especially the G1/S transition, forcing the cell into DNA replication despite potential errors or damage, which is a critical step in oncogenesis.
Rb Protein
The Rb protein, or retinoblastoma protein, is a key regulator of the cell cycle transition from G1 to S phase. It acts as a tumor suppressor by inhibiting the activity of E2F transcription factors, which are necessary for the progression of the cell cycle into the S-phase. When Rb is inactivated, such as through phosphorylation or by binding of viral proteins (e.g., from HPV or EBV), E2F is released and activates the transcription of genes that are required for DNA synthesis and other S-phase functions.
E2F Transcription Factor
E2F transcription factors are crucial for controlling the expression of genes involved in DNA replication, repair, and cell cycle progression. When bound by Rb protein, their activity is inhibited, preventing premature S-phase entry.
Viral oncogenes can disrupt this regulation by inactivating Rb, freeing E2F to stimulate the transcription of S-phase genes. This action by viruses like EBV, which binds and inactivates Rb, underscores their role in promoting cell cycle progression and potentially leading to oncogenic transformation.
S-phase Entry
Entry into the S-phase of the cell cycle is a critical point of regulation. This phase is where DNA replication occurs, and it needs to be tightly controlled to prevent genomic instability. The G1/S checkpoint ensures that all conditions are favorable for DNA synthesis, and it involves several proteins, including Rb and E2F.
Viruses can influence this checkpoint by manipulating Rb's ability to restrain E2F activity, thus causing the unregulated transcription of S-phase genes and promoting S-phase entry, which can lead to genomic instability and an increased risk of cancerous transformation.